Search results for: OHE Consulting
Filter search results
Lavni Varyani
19 September 2025
Lavni Varyani is the Founding Partner of Pharma BP, with c. 14 years of experience in life sciences consulting across the GCC and MENA. She previously worked at IMS Consulting…
NICE ‘Optimised’ Recommendations: What Do They Mean for Patient Access?
30 July 2020
OHE publishes a report quantifying the level of patient access associated with NICE ‘optimised’ recommendations. OHE publishes a report quantifying the level of patient access associated with NICE ‘optimised’ recommendations….
Defining Innovation in Medicines and Transforming it into Value
3 July 2013
…Innovation into Value from Office of Health Economics This presentation is based in part on a recent OHE Consulting report, The Many Faces of Innovation, which is available for download…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
…DOI | RePEc Towse, A. and Garau, M., 2018. Appraising ultra-orphan drugs: is cost-per QALY appropriate? A review of the evidence. OHE Consulting Report. London: Office of Health Economics. RePEc…
New Publication: Advanced Therapy Medicinal Products and Health Technology Assessment
12 October 2018
…OHE’s Grace Hampson and Adrian Towse, alongside Bengt Jönsson (Stockholm School of Economics), Jonathan Michaels (University of Sheffield), J.-Matthias von der Schulenburg (Leibniz University, Hannover), and Olivier Wong (Medi-Qualite Omega),…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…Sussex, J. and Lorgelly, P., 2019. Making Outcome-Based Payment a Reality in the NHS. OHE, RAND Europe, KCL and Cancer Research UK Research Paper. Available at: https://www.ohe.org/publications/making-outcome-based-payment-reality-nhs Cole, A., Towse,…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…these barriers, which were developed through an expert roundtable project, sponsored by Pfizer, soon to be published as an OHE Consulting Report. Louis Garrison (Professor Emeritus at the CHOICE Institute,…
The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis
30 June 2022
…value of a novel orphan medicine. Related research Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Garau,…
Obstructive Sleep Apnoea: Health Economics Report
1 September 2014
…85% of OSA cases currently are undiagnosed and untreated in the UK. In this report, OHE Consulting calculates the direct savings that could be realised if more cases were treated….